In hematopoietic cancer cells, IFN-β signaling can directly restore RB1 function by increasing its gene expression or protein activation with reduction of its phosphorylation to induce an RB1-mediated G1/G0 growth arrest. This evidence concerns the gene RB1 and hematopoietic and lymphoid cell neoplasm.